0,866  0,004  Cardiovascular analeptic
0,701  0,012  GST A substrate
0,604  0,008  Ulceration
0,591  0,002  Electron transport complex I inhibitor
0,587  0,016  Sensitization
0,554  0,019  5 Hydroxytryptamine release stimulant
0,538  0,022  5 Hydroxytryptamine release inhibitor
0,529  0,028  Cholesterol antagonist
0,505  0,032  Immunosuppressant
0,476  0,025  FMO1 substrate
0,524  0,078  Antiinflammatory
0,483  0,038  Antipruritic, allergic
0,450  0,005  Pneumotoxic
0,420  0,018  Eye irritation, high
0,407  0,011  GST M1-1 substrate
0,408  0,015  Abortion inducer
0,418  0,027  UGT2B4 substrate
0,422  0,034  Lipoprotein disorders treatment
0,464  0,076  Caspase 9 stimulant
0,408  0,026  Antipyretic
0,404  0,024  Antiparasitic
0,408  0,032  Cytostatic
0,382  0,010  Tyrosine 3 hydroxylase inhibitor
0,430  0,060  Histamine release inhibitor
0,377  0,010  Acaricide
0,385  0,028  Hypolipemic
0,414  0,058  CYP2C9 substrate
0,417  0,072  TNF expression inhibitor
0,356  0,011  Protein kinase stimulant
0,363  0,022  5 Hydroxytryptamine uptake stimulant
0,339  0,004  GABA C receptor antagonist
0,363  0,039  Antineoplastic (multiple myeloma)
0,371  0,049  Antihypercholesterolemic
0,366  0,045  CTGF expression inhibitor
0,384  0,067  CYP3A4 substrate
0,329  0,017  Gastrin inhibitor
0,331  0,026  Antihelmintic
0,359  0,056  Antihypertensive
0,305  0,013  Phospholipase A2 inhibitor
0,307  0,016  Neurotrophic factor enhancer
0,327  0,041  Antiglaucomic
0,314  0,030  Anesthetic general
0,334  0,050  UGT1A9 substrate
0,289  0,011  Carcinogenic, group 1
0,323  0,050  Antineoplastic (endocrine cancer)
0,280  0,008  ATPase inhibitor
0,364  0,094  Antibacterial
0,335  0,070  Antithrombotic
0,322  0,057  Teratogen
0,341  0,078  Vasodilator, peripheral
0,314  0,052  NOS2 expression inhibitor
0,321  0,063  Analeptic
0,320  0,062  Sodium/bile acid cotransporter inhibitor
0,326  0,068  Calcium channel activator
0,280  0,026  Antipruritic, non-allergic
0,376  0,125  Apoptosis agonist
0,265  0,020  GST P1-1 substrate
0,301  0,058  Embryotoxic
0,281  0,040  Platelet adhesion inhibitor
0,266  0,025  Interferon gamma antagonist
0,296  0,056  Flavin-containing monooxygenase substrate
0,265  0,025  Hair growth stimulant
0,259  0,021  Interleukin 6 antagonist
0,275  0,038  RNA-directed DNA polymerase inhibitor
0,273  0,036  Peptidyltransferase inhibitor
0,252  0,017  Cholesterol synthesis inhibitor
0,261  0,027  Skin irritative effect
0,258  0,026  Antiparkinsonian, tremor relieving
0,315  0,087  Transcription factor NF kappa B inhibitor
0,231  0,004  Antihypermotility
0,284  0,058  Proliferative diseases treatment
0,269  0,043  Antihypotensive
0,255  0,032  Sepsis treatment
0,275  0,053  DNA synthesis inhibitor
0,250  0,030  Antiacne
0,234  0,015  GABA C receptor rho-2 antagonist
0,352  0,137  Antineoplastic (solid tumors)
0,277  0,067  Chemoprotective
0,315  0,106  GABA C receptor rho-3 antagonist
0,225  0,017  Antirickettsial
0,212  0,005  GST T1-1 substrate
0,216  0,010  Antineoplastic alkaloid
0,221  0,015  Microtubule formation inhibitor
0,226  0,024  Uterine stimulant
0,238  0,038  Lipocortins synthesis antagonist
0,289  0,091  Antineoplastic (small cell lung cancer)
0,217  0,019  Arachidonic acid antagonist
0,278  0,082  Lipoxygenase inhibitor
0,203  0,011  Vanilloid 1 agonist
0,224  0,033  Succinate dehydrogenase inhibitor
0,238  0,046  UGT2B7 substrate
0,241  0,051  Antialcoholic
0,270  0,081  CYP2C19 substrate
0,246  0,057  Antiparkinsonian, rigidity relieving
0,241  0,054  Chemopreventive
0,209  0,025  Antihyperlipoproteinemic
0,266  0,083  Radioprotector
0,272  0,089  NOS3 expression inhibitor
0,197  0,013  Photosensitizer
0,244  0,062  Antiulcerative
0,236  0,055  VCAM1 expression inhibitor
0,278  0,097  AR expression inhibitor
0,255  0,074  Hypoglycemic
0,210  0,030  UGT2B10 substrate
0,243  0,064  Cytotoxic
0,267  0,090  Immunostimulant
0,180  0,007  Interferon agonist
0,175  0,004  Glycine receptor antagonist
0,176  0,006  Ornithine decarboxylase inhibitor
0,198  0,029  DNA polymerase I inhibitor
0,180  0,012  GABA C receptor rho-1 antagonist
0,202  0,034  Alpha-N-acetylglucosaminidase inhibitor
0,176  0,009  Ca2+-transporting ATPase inhibitor
0,172  0,005  Glycine receptor agonist
0,193  0,027  Proteasome inhibitor
0,275  0,110  Vasodilator, coronary
0,267  0,101  Interleukin 2 agonist
0,198  0,033  Antifungal enhancer
0,249  0,086  Radiosensitizer
0,181  0,020  Constipation treatment
0,262  0,101  Antifungal
0,235  0,075  Cardiodepressant
0,175  0,018  TRPA1 agonist
0,231  0,074  Cyclic AMP phosphodiesterase inhibitor
0,179  0,022  Choleretic
0,267  0,111  ICAM1 expression inhibitor
0,179  0,025  GABA C receptor agonist
0,169  0,016  Prolactin inhibitor
0,170  0,018  Chronic obstructive bronchitis treatment
0,169  0,018  Antispirochetal
0,212  0,062  Insulin sensitizer
0,209  0,059  Sigma receptor agonist
0,177  0,027  Sphingosine 1-phosphate receptor 5 antagonist
0,219  0,070  Psychostimulant
0,180  0,032  Topoisomerase I inhibitor
0,213  0,065  Carcinogenic
0,160  0,013  Anabolic
0,202  0,056  Diabetic nephropathy treatment
0,207  0,062  CYP2B6 inhibitor
0,246  0,103  Respiratory analeptic
0,185  0,042  Genotoxic
0,155  0,013  Paget's disease treatment
0,187  0,046  UGT2B9 substrate
0,258  0,120  Apoptosis antagonist
0,167  0,029  Coagulant
0,206  0,068  UGT1A1 substrate
0,245  0,107  FMO3 substrate
0,231  0,094  Interleukin agonist
0,183  0,047  CNS active muscle relaxant
0,165  0,031  Antiviral (Poxvirus)
0,156  0,022  Hedgehog signaling inhibitor
0,190  0,058  Antimutagenic
0,229  0,098  5 Hydroxytryptamine 1E antagonist
0,175  0,045  Carcinogenic, group 3
0,133  0,005  Interferon inducer
0,161  0,034  Carcinogenic, group 2B
0,205  0,078  Platelet aggregation inhibitor
0,186  0,059  UGT1A3 substrate
0,197  0,074  Non-steroidal antiinflammatory agent
0,145  0,022  Acetylcholine M3 receptor agonist
0,143  0,022  Electrolyte absorption antagonist
0,212  0,092  Antiviral (West Nile virus)
0,160  0,040  Cyclooxygenase 3 inhibitor
0,135  0,016  Interleukin 5 antagonist
0,148  0,030  Antineoplastic, alkylator
0,126  0,009  Acetylcholine M5 receptor agonist
0,137  0,021  Phosphofructokinase-1 inhibitor
0,210  0,094  Platelet antagonist
0,257  0,141  Antineoplastic (breast cancer)
0,140  0,024  Actinic keratosis treatment
0,122  0,007  Antimycoplasmal
0,129  0,014  Leukotriene synthesis inhibitor
0,214  0,101  Calpain inhibitor
0,157  0,046  Anesthetic local
0,179  0,068  UGT1A4 substrate
0,202  0,092  UGT1A6 substrate
0,114  0,004  Cholesterol esterase inhibitor
0,199  0,090  Nitric-oxide synthase stimulant
0,190  0,082  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,215  0,108  Spasmolytic
0,160  0,053  Hearing loss treatment
0,170  0,063  Neurotensin receptor agonist
0,173  0,068  Phospholipase C inhibitor
0,169  0,064  Cystic fibrosis treatment
0,128  0,024  Tourette's syndrome treatment
0,225  0,121  CYP2D6 substrate
0,148  0,047  Cathepsin H inhibitor
0,116  0,018  Na+ K+ transporting ATPase inhibitor
0,127  0,029  UGT2B11 substrate
0,112  0,015  Prokinetic
0,171  0,073  Toxic, respiratory center
0,135  0,038  Antifungal (Pneumocystis)
0,116  0,020  Lipase inhibitor
0,106  0,009  Fatty acid synthase inhibitor
0,194  0,098  Angiogenesis stimulant
0,118  0,022  Bile acid receptor antagonist
0,128  0,035  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,104  0,012  Phosphodiesterase VIII inhibitor
0,137  0,046  Contraceptive female
0,137  0,046  Glutathione S-transferase substrate
0,171  0,081  Nitric oxide antagonist
0,152  0,063  SULT1A3 substrate
0,159  0,070  Diuretic
0,101  0,013  Protein 50S ribosomal subunit inhibitor
0,180  0,092  VEGF expression inhibitor
0,099  0,011  Glutamate (mGluR6) antagonist
0,155  0,067  CF transmembrane conductance regulator agonist
0,128  0,041  UGT2B1 substrate
0,139  0,053  Alkylator
0,194  0,108  Aldehyde oxidase inhibitor
0,132  0,046  Antiviral (Influenza B)
0,094  0,009  Smo receptor antagonist
0,241  0,156  Calpain 2 inhibitor
0,140  0,055  Sphingosine 1-phosphate receptor 2 antagonist
0,110  0,024  Vanilloid agonist
0,092  0,007  Anesthetic inhalation
0,160  0,076  Antihelmintic (Nematodes)
0,156  0,074  Melanin inhibitor
0,130  0,048  SULT1A1 substrate
0,148  0,066  Adenylate cyclase stimulant
0,099  0,017  Vanilloid 4 agonist
0,106  0,025  CDC25A inhibitor
0,109  0,029  ATPase (Vacuolar H+) inhibitor
0,151  0,071  Antiischemic, cerebral
0,152  0,072  Raynaud's phenomenon treatment
0,145  0,066  Antifungal (Cryptococcus)
0,169  0,090  Hepatoprotectant
0,133  0,055  Beta amyloid protein antagonist
0,168  0,090  Sedative
0,119  0,042  Sphingomyelinase inhibitor
0,180  0,104  5 Hydroxytryptamine 3E antagonist
0,184  0,109  Antineoplastic (glioma)
0,249  0,174  CYP2C19 inhibitor
0,085  0,011  Nicotinic alpha3beta2 receptor antagonist
0,125  0,051  Excitatory amino acid transporter EAAC1 inhibitor
0,108  0,035  Restless leg syndrome treatment
0,101  0,028  Acetylcholine M4 receptor antagonist
0,124  0,051  Ferrochelatase inhibitor
0,105  0,032  Antibiotic
0,117  0,046  Adenylate kinase inhibitor
0,076  0,005  Cytokine production stimulant
0,138  0,068  Farnesoid X receptor antagonist
0,128  0,058  Sphingosine 1-phosphate receptor 4 antagonist
0,182  0,113  Antiamyloidogenic
0,155  0,087  Muscle relaxant
0,077  0,010  Glucose-6-phosphate isomerase inhibitor
0,074  0,007  Acetylcholine M4 receptor agonist
0,107  0,040  Antiviral (Rhinovirus)
0,085  0,019  Antiviral (Parainfluenza)
0,120  0,054  Mucolytic
0,102  0,036  Glutathione S-transferase inhibitor
0,119  0,053  Aminopeptidase B inhibitor
0,077  0,013  Potassium channel Kv1.3 blocker
0,151  0,087  Prostate disorders treatment
0,080  0,016  Peristaltic stimulant
0,143  0,080  Antidiarrheal
0,146  0,082  Pulmonary hypertension treatment
0,134  0,071  Anesthetic
0,095  0,033  Keratolytic
0,085  0,024  Protease 3C (Human rhinovirus) inhibitor
0,073  0,012  Squalene epoxidase inhibitor
0,083  0,024  Glutamate (mGluR7) antagonist
0,081  0,022  Acyl-CoA dehydrogenase inhibitor
0,124  0,064  Growth stimulant
0,081  0,022  Prostaglandin F2 alpha antagonist
0,127  0,068  Antiseptic
0,175  0,118  Antineoplastic (lymphoma)
0,137  0,080  Skeletal muscle relaxant
0,094  0,037  Nicotinic alpha4beta2 receptor antagonist
0,078  0,021  Phosphodiesterase 1C inhibitor
0,204  0,148  CYP1A2 substrate
0,088  0,032  Sphingosine 1-phosphate receptor 4 agonist
0,081  0,025  Argininosuccinate synthase inhibitor
0,076  0,020  Sphingosine 1-phosphate receptor 3 antagonist
0,157  0,101  Phobic disorders treatment
0,104  0,049  Lanosterol 14 alpha demethylase inhibitor
0,182  0,127  Antineoplastic (liver cancer)
0,132  0,079  Antineoplastic (squamous cell carcinoma)
0,063  0,010  Nicotinic acid receptor agonist
0,079  0,026  Exportin-1 inhibitor
0,134  0,082  UGT2B15 substrate
0,164  0,112  Anticonvulsant
0,138  0,087  Acetylcholine M1 receptor antagonist
0,106  0,055  Dementia treatment
0,073  0,021  Phosphodiesterase 1A inhibitor
0,189  0,138  Antineoplastic (pancreatic cancer)
0,094  0,044  Granulocyte macrophage colony stimulating factor agonist
0,103  0,053  Glutamate (mGluR7) agonist
0,081  0,031  Potassium channel (Tandem pore domain) blocker
0,060  0,010  DNA gyrase subunit A inhibitor
0,068  0,018  Alpha-mannosidase inhibitor
0,061  0,011  Guanylate cyclase inhibitor
0,103  0,054  Vascular dementia treatment
0,074  0,025  Acetylcholine muscarinic agonist
0,098  0,049  Triose-phosphate isomerase inhibitor
0,130  0,081  Neurotrophic factor
0,054  0,007  Prostaglandin D2 agonist
0,067  0,020  Acetylcholine M1 receptor agonist
0,180  0,134  DNA damaging
0,088  0,042  CYP2A6 inhibitor
0,057  0,012  RNA-directed RNA polymerase stimulant
0,158  0,113  Antineoplastic (glioblastoma multiforme)
0,049  0,004  Nicotinic acid receptor 2 antagonist
0,076  0,031  Cannabinoid CB1 receptor agonist
0,055  0,010  Glutamate (mGluR3) antagonist
0,049  0,004  Calcium-independent phospholipase A2 inhibitor
0,106  0,062  Antiinfertility, female
0,048  0,004  Prostaglandin F2 alpha agonist
0,152  0,108  LDLR expression enhancer
0,095  0,051  Calcium antagonist
0,072  0,029  Androgen agonist
0,094  0,052  Antidote, mercury
0,116  0,073  Alcohol dehydrogenase substrate
0,094  0,052  Phosphodiesterase I inhibitor
0,105  0,063  Expectorant
0,068  0,027  Sphingosine kinase inhibitor
0,132  0,091  Antiviral (Influenza A)
0,128  0,088  Cell wall synthesis inhibitor
0,053  0,014  Membrane dipeptidase inhibitor
0,142  0,102  Antiviral (Hepatitis C)
0,071  0,032  Hypercalcemia treatment
0,065  0,026  Sphingosine kinase 2 inhibitor
0,118  0,080  Toll-Like receptor 2 antagonist
0,042  0,004  Vanilloid 2 agonist
0,047  0,009  ATP citrate lysase inhibitor
0,051  0,014  Arginase inhibitor
0,090  0,053  Dyspepsia treatment
0,090  0,054  Carcinogenic, group 2A
0,063  0,026  Thromboxane A2 antagonist
0,088  0,052  mTOR complex 2 inhibitor
0,048  0,013  Delayed rectifier potassium channel blocker
0,060  0,024  5 Hydroxytryptamine 4 antagonist
0,082  0,047  Catalase inhibitor
0,049  0,014  Kainate receptor agonist
0,103  0,068  Antiprotozoal (Toxoplasma)
0,042  0,007  Motilin receptor agonist
0,057  0,022  Oleamide hydrolase inhibitor
0,150  0,115  Antiviral (Hepatitis)
0,087  0,053  Antiviral (Trachoma)
0,160  0,126  Potassium channel blocker
0,054  0,021  Mannosidase inhibitor
0,106  0,073  Acetylcholine release stimulant
0,063  0,030  Thromboxane antagonist
0,089  0,057  Tocolytic
0,056  0,024  HCV NS3/NS4A protease inhibitor
0,170  0,139  Myocardial infarction treatment
0,060  0,029  Leukotriene C antagonist
0,045  0,015  Sirtuin 2 inhibitor
0,060  0,030  Acetyl-CoA transferase inhibitor
0,087  0,057  Antileprosy
0,109  0,079  Antineoplastic antimetabolite
0,071  0,042  SULT2A1 substrate
0,106  0,077  Aldehyde dehydrogenase substrate
0,066  0,037  Carbamoyl phosphate synthetase inhibitor
0,094  0,066  Creatine kinase inhibitor
0,070  0,042  Bcl2 antagonist
0,035  0,008  Lysophosphatidic acid receptor 1 agonist
0,044  0,017  Nicotinic acid receptor 2 agonist
0,123  0,097  Peroxidase inhibitor
0,063  0,038  Phosphodiesterase 1B inhibitor
0,040  0,015  Melatonin 2 agonist
0,137  0,111  Antipruritic
0,035  0,010  Potassium channel (Inward rectifier) 1 blocker
0,183  0,159  Transcription factor STAT3 inhibitor
0,114  0,089  Contraceptive
0,067  0,043  Cannabinoid receptor agonist
0,033  0,009  Hedgehog signaling activator
0,069  0,046  Gaucher disease treatment
0,031  0,008  Acid ceramidase inhibitor
0,040  0,017  Glutamate (mGluR8) antagonist
0,054  0,032  Aconitate hydratase inhibitor
0,192  0,170  Insulysin inhibitor
0,051  0,030  Antiviral (Herpesvirus 3, Human)
0,043  0,021  Cholesterol absorption inhibitor
0,167  0,145  Antioxidant
0,076  0,055  Narcotic antagonist
0,055  0,034  Leukotriene B4 antagonist
0,044  0,024  Sphingosine kinase 1 inhibitor
0,037  0,017  Melatonin receptor 1A agonist
0,036  0,016  Prostaglandin agonist
0,057  0,038  Pregnane X receptor antagonist
0,075  0,057  Estrogen receptor alpha antagonist
0,067  0,049  Endocannabinoid uptake inhibitor
0,104  0,086  Acetylcholine muscarinic antagonist
0,077  0,059  Antidote, organophosphates
0,049  0,031  Aldosterone antagonist
0,055  0,037  Cannabinoid CB2 receptor agonist
0,045  0,028  Leukocyte elastase inhibitor
0,128  0,111  Neuropathy treatment
0,123  0,107  Hemostatic
0,021  0,005  Thromboxane A2 agonist
0,025  0,008  Neuraminidase (Influenza B) inhibitor
0,035  0,020  Melatonin agonist
0,069  0,054  Aminopeptidase I inhibitor
0,020  0,005  Lysophosphatidic acid receptor 3 agonist
0,080  0,066  Estrogen-related receptor beta agonist
0,035  0,021  Melatonin 1 agonist
0,050  0,037  Cannabinoid CB2 receptor antagonist
0,027  0,013  Prostaglandin EP2 agonist
0,088  0,075  Interleukin 1 beta converting enzyme inhibitor
0,146  0,133  Antihypertriglyceridemic
0,041  0,028  Plasmepsin II inhibitor
0,057  0,044  Cathepsin E inhibitor
0,044  0,031  Nicotinic receptor alpha3 subunit antagonist
0,039  0,027  Leukotriene C4 antagonist
0,067  0,054  Protein kinase C beta inhibitor
0,026  0,014  5 Hydroxytryptamine 4 agonist
0,049  0,037  Lysophosphatidic acid 3 receptor antagonist
0,068  0,056  Cathepsin G inhibitor
0,093  0,081  AMP-activated protein kinase stimulant
0,029  0,018  Purinergic P2Y15 antagonist
0,024  0,013  Isoleucine-tRNA ligase inhibitor
0,034  0,023  Free fatty acid receptor 1 antagonist
0,056  0,046  Lipocortins synthesis agonist
0,045  0,036  Peroxisome proliferator-activated receptor alpha agonist
0,072  0,063  Antineoplastic antibiotic
0,014  0,005  Thromboxane agonist
0,054  0,045  Aromatase inhibitor
0,054  0,046  Postcoital contraceptive
0,041  0,033  Histamine H2 receptor agonist
0,124  0,117  Pregnane X receptor agonist
0,046  0,039  Potassium channel (Inward rectifier) blocker
0,036  0,030  Glutamate (mGluR8) agonist
0,109  0,102  Antiviral (Papilloma)
0,114  0,108  Mutagenic
0,049  0,044  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,106  0,100  Bone formation stimulant
0,031  0,026  Glutamate (mGluR3) agonist
0,047  0,042  Ornithine carbamoyltransferase inhibitor
0,051  0,046  Beta 1 adrenoreceptor antagonist
0,100  0,095  Menstruation disorders treatment
0,050  0,045  Alcohol oxidase inhibitor
0,042  0,038  Microtubule stabilization
0,021  0,017  GRP78 expression inhibitor
0,013  0,010  Antibiotic Macrolide-like
0,022  0,018  Prostaglandin E2 agonist
0,120  0,117  Thiol protease inhibitor
0,031  0,028  Retinoid X receptor agonist
0,022  0,020  Sodium/glucose cotransporter 1 inhibitor
0,018  0,016  Alpha 2b adrenoreceptor agonist
0,084  0,082  UDP-glucose 4-epimerase inhibitor
0,046  0,044  Potassium channel (Inward rectifier) activator
0,057  0,056  Antiemphysemic
0,044  0,043  Potassium channel (ATP-sensitive) activator
0,100  0,099  Aldehyde dehydrogenase inhibitor
0,016  0,015  Telomerase stimulant
0,068  0,067  SULT1A2 substrate
0,086  0,086  Mediator release inhibitor
0,028  0,028  Estradiol 17 beta-dehydrogenase 3 inhibitor

